Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2012
In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancerDuha Fahham, Ido D Weiss, Michal Abraham, et al.
Journal of the Neurological Sciences|September 23, 2008
New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunityHirofumi Ochi, Michal Abraham, Hiroki Ishikawa, et al.
Research Square|March 4, 2025
BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) PathwayAmnon Peled, Michal Abraham, Hanna Wald, et al.
Biomedicines|February 25, 2023
CDC25C Protein Expression Correlates with Tumor Differentiation and Clinical Outcomes in Lung AdenocarcinomaEsther Stern, Guy Pines, Li Or Lazar, et al.
Nature Medicine|May 23, 2006
Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cellsHirofumi Ochi, Michal Abraham, Hiroki Ishikawa, et al.
Hepatology (Baltimore, Md.)|March 26, 2013
Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in miceNeta Barashi, Ido D Weiss, Ori Wald, et al.
Experimental Hematology|December 9, 2010
CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growthKatia Beider, Michal Begin, Michal Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 PathwayKatia Beider, Evgenia Rosenberg, Hanna Bitner, et al.
Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2017
Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy VolunteersMichal Abraham, Yaron Pereg, Baruch Bulvik, et al.
Pageof 4